Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial

Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial

Spicer, J., Basu, B., Montes, A., Banerji, U., Kristeleit, R., Miller, R., Veal, G. J., Corrigan, C. J., Till, S. J., Figini, M., Canevari, S., Barton, C., Jones, P., Mellor, S., Carroll, S., Selkirk, C., Nintos, G., Kwatra, V., Funingana, I.-G. & Doherty, G. & 12 others, Gould, H. J., Pellizzari, G., Nakamura, M., Ilieva, K. M., Khiabany, A., Stavraka, C., Chauhan, J., Gillett, C., Pinder, S., Bax, H. J., Josephs, D. H. & Karagiannis, S. N., 25 Jul 2023, In: Nature Communications. 14, 1, p. 4180 4180.

Research output: Contribution to journal › Article › peer-review